Literature DB >> 12951239

A detailed kinetic study of Mox-1, a plasmid-encoded class C beta-lactamase.

Jimena Alba1, Cedric Bauvois, Yoshikazu Ishii, Moreno Galleni, Katsuyoshi Masuda, Masaji Ishiguro, Masahiko Ito, Jean-Marie Frere, Keizo Yamaguchi.   

Abstract

Surveys of beta-lactamases in different parts of the world show an important increase in class C beta-lactamases, thus the study of these enzymes is becoming an important issue. We created an overproduction system for Mox-1, a plasmid class C beta-lactamase, by cloning the gene encoding this enzyme, and placing it under the control of a T7 promoter, using vector pET 28a. The enzyme, purified by ion exchange chromatography, was used to obtain the molecular mass (38246), the N-terminal sequence (GEASPVDPLRPVV), and pI (8.9), and to perform a detailed kinetic study. Cephalotin was used as reporter substrate in the case of poor substrates. The kinetic study showed that benzylpenicillin, cephalotin, cefcapene and moxalactam were good substrates for Mox-1 (k(cat)/K(m) values >2.5 x 10(6) M(-1) s(-1)). On the other hand, ceftazidime and cefepime were poor substrates for this enzyme (K(m) values >200 microM). Clavulanic acid had no inhibitory effect on Mox-1 (K(m)=30.2 mM), however aztreonam behaved as an inhibitor of Mox-1 (K(i)=2.85 microM).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12951239     DOI: 10.1016/S0378-1097(03)00448-8

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  7 in total

1.  Crystal structure of Mox-1, a unique plasmid-mediated class C β-lactamase with hydrolytic activity towards moxalactam.

Authors:  Takuma Oguri; Takamitsu Furuyama; Takashi Okuno; Yoshikazu Ishii; Kazuhiro Tateda; Robert A Bonomo; Akiko Shimizu-Ibuka
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

2.  Conformational Change Observed in the Active Site of Class C β-Lactamase MOX-1 upon Binding to Aztreonam.

Authors:  Takuma Oguri; Yoshikazu Ishii; Akiko Shimizu-Ibuka
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

3.  Novel SHV-derived extended-spectrum beta-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin.

Authors:  Ling Ma; Jimena Alba; Feng-Yee Chang; Masaji Ishiguro; Keizo Yamaguchi; L K Siu; Yoshikazu Ishii
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

4.  Molecular and Kinetic Characterization of MOX-9, a Plasmid-Mediated Enzyme Representative of a Novel Sublineage of MOX-Type Class C β-Lactamases.

Authors:  Alessandra Piccirilli; Alberto Antonelli; Marco Maria D'Andrea; Sabrina Cherubini; Mariagrazia Perilli; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2022-08-30       Impact factor: 5.938

Review 5.  Class C β-Lactamases: Molecular Characteristics.

Authors:  Alain Philippon; Guillaume Arlet; Roger Labia; Bogdan I Iorga
Journal:  Clin Microbiol Rev       Date:  2022-04-18       Impact factor: 50.129

6.  Role of a mutation at position 167 of CTX-M-19 in ceftazidime hydrolysis.

Authors:  Soichiro Kimura; Masaji Ishiguro; Yoshikazu Ishii; Jimena Alba; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

7.  Insights Into the Inhibition of MOX-1 β-Lactamase by S02030, a Boronic Acid Transition State Inhibitor.

Authors:  Tatsuya Ishikawa; Nayuta Furukawa; Emilia Caselli; Fabio Prati; Magdalena A Taracila; Christopher R Bethel; Yoshikazu Ishii; Akiko Shimizu-Ibuka; Robert A Bonomo
Journal:  Front Microbiol       Date:  2021-12-14       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.